New patient of Hansen's disease in young Korean man

Jin-Mo Park; Jong-Pill Kim; Kuk-Hyeong Kang

doi:10.33161/klb.2018.51.1.23

Journal List > Korean Lepr Bull > v.51(1) > 1109698

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Park, Kim, and Kang: New patient of Hansen's disease in young Korean man

Case Report

Korean Leprosy Bulletin 2018; 51(1): 23-28.

Published online: 20 December 2018

DOI: https://doi.org/10.33161/klb.2018.51.1.23

New patient of Hansen's disease in young Korean man

Jin-Mo Park, Jong-Pill Kim, Kuk-Hyeong Kang

Institute for Leprosy Research, Korean Hansen Welfare Association, Korea.

Corresponding author Jin-Mo Park. (hafler@hanmail.net)

Received 19 October 2018 Accepted 10 December 2018

Abstract

Hansen's disease (leprosy) is a chronic infectious disease caused by Mycobacterium leprae which affect mainly skin and nerve systems. Currently the incidence of leprosy reached the goals set by WHO in the year 2000. In recent 10 years, only 47 new patients were found in Koreans and their average age was over 70. A 21 year-old young man showed multiple erythematous papules, macules and plaque at face, extremities and trunk. In family history, his grandfather was diagnosed with leprosy at young age and leprosy was recurred when the patient was 7 years old. The patient lived with grandfather from birth to 7 years old. Clinico-pathologically he was diagnosed with a lepromatous leprosy. We performed VNTR both at the skin tissue of grandfather and patient to find out the infection pathway of the patient and found some consistent. Herein, we report a new case of young Korean male transmitted from grandfather.

Keywords: Hansen's disease, Lepromatous leprosy, Variable number tandem repeats

Figures and Tables

Fig. 1

Fig. 1A. Grenz zone in the upper dermis, dense peri-neurovascular cellular infiltration at the upper and lower dermis (H&E ×100). Fig. 1B. Lymphocytic infiltration and macrophages containing foamy and vacuolated cytoplasm(H&E ×200). Fig. 1C. Acid-fast bacilli stain positive at the dermis(×400).

Fig. 2

Multiple bilateral and symmetrical erythematous papular macules, nodules and patches at both palm and trunk. Some papules, nodules and patches at arm and leg.

Fig. 3

Fig. 3A. Grenz zone in the upper dermis. Extensive cellular infiltrate in the upper and lower dermis (H&E ×100). Fig. 3B. Mass of macrophages in the dermis (H&E ×200). Fig. 3C. Acid-fast bacilli stain positive at the dermis (×400).

Table 1

Result of VNTR from the skin tissue of grandfather and patient

References

1. Meyers WM, Walsh GP, Brown HL, Binford CH, Imes GD Jr, Hadfield TL, et al. Leprosy in a mangabey monkey-naturally acquired infection. Int J Lepr Other Mycobact Dis. 1985; 53:1–14.

2. Leininger JR, Donham KJ, Meyers WM. Leprosy in a chimpanzee. Postmortem lesions. Int J Lepr Other Mycobact Dis. 1980; 48:414–442.

3. Truman RW, Singh P, Sharma R, Busso P, Rougemont J, Paniz-Mondolfia , et al. Probable zoonotic leprosy in the southern United States. N Engl J Med. 2011; 364:1626–1633.

4. Kim JP. Leprosy on Korea. 2001-2015: Situation, International Migration and Perspectives. Korean Leprosy bullet. 2016; 49:37–34.

5. Reibel F, Cambau E, Aubry A. Update on the epidemiology, diagnosis, and the treatment of leprosy. Med Mal Infect. 2015; 45:383–393.

6. KHWA. Current situation and major indicator of Hansen's service program in Korea. Uiwang, Korea: KHWA;2009.

7. Lee DJ, Rea TH, Modlin RL. Leprosy. In : Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw-Hill;2012. p. 2253–2263.

8. Ridley DS, Jopling WH. A classification of leprosy for research purposes. Lepr Rev. 1962; 33:119–128.

9. Pedley JC. The nasal mucus in leprosy. Lepr Rev. 1973; 44:33–35.

10. Morgado de Abreu MA, Roselino AM, Enokihara M, Nonogaki S, Prestes-Carneiro LE, Weckx LL, et al. Mycobacterium leprae is identified in the oral mucosa from paucibacillary and multibacillary leprosy patients. Clin Microbiol Infect. 2014; 20:59–64.

11. Baohong J. Does there exist a subgroup of MB patients at greater risk of relapse after MDT. Lepr Rev. 2001; 72:3–7.

12. Gelber RH, Balagon VF, Cellona RV. The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low. Int J Lepr other Mycobact Dis. 2004; 72:493–500.

13. Hughes CR, Queller DC. Detection of highly polymorphic microsatellite loci in a species with little allozyme polymorphism. Mol Ecol. 1993; 2:131–137.

14. Hall BG, Salipante SJ. Molecular epidemiology of Mycobacterium leprae as determined by structure-neighbor clustering. J Clin Microbiol. 2010; 48:1997–2008.

15. Suzuki K, Udono T, Fujisawa M, Tanigawa K, Idani G, Ishii N. Infection during infancy and long incubation period of leprosy suggested in a case of a chimpanzee used for medical research. J Clin Microbiol. 2010; 48:3432–3434.

16. Gaschignard J, Scurr E, Alcais A. Leprosy, a pillar of human genetics of infectious diseases. Pathol Biol. 2013; 61:120–128.

17. Saucr MED, Salomao H, Ramos GB, D'Espindula HRS, Rodrigues RSA, Macedo Wc, et al. Genetics of leprosy: expected-and unexpected-developments and perspectives. Clin Dermatol. 2016; 34:96–104.

18. Cambri G, Mira MT. Genetic Susceptibility to Leprosy-From Classic Immune-Related Candidate Genes to Hypothesis-Free, Whole Genome Approaches. Front Immunol. 2018; 9:1674.

TOOLS

Similar articles